Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis.

Guptill, Jeffrey T; Runken, M Chris; Eaddy, Michael; Lunacsek, Orsolya; Fuldeore, Rupali M

Guptill, Jeffrey T; Runken, M Chris; Eaddy, Michael; Lunacsek, Orsolya; Fuldeore, Rupali M.

Afiliación

Guptill JT; Associate Professor of Neurology, Duke Clinical Research Institute, Duke University, Durham, NC.
Runken MC; Senior Director Global HEOR, Grifols SSNA, Research Triangle Park, NC.
Eaddy M; Vice President, Scientific Consulting, Xcenda, Palm Harbor, FL.
Lunacsek O; Director, Scientific Consulting, Xcenda.
Fuldeore RM; Manager, Scientific Consulting, Xcenda.

Am Health Drug Benefits ; 12(3): 127-135, 2019 May.

Article en En | MEDLINE | ID: mdl-31346365

Palabras clave

CIDP; IVIG; chronic inflammatory demyelinating polyneuropathy; economic burden; healthcare costs; intravenous immunoglobulin; plasma exchanges; steroids; treatment patterns

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am Health Drug Benefits Año: 2019 Tipo del documento: Article País de afiliación: Nueva Caledonia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google